source
- FDA nominee Heidi Overton pledges faster drug trials to keep US biotech competitiveHeidi Overton, President Trump's nominee for FDA commissioner, will appear before a Senate committee to outline her priorities for the agency. She said the administration wants her to 'go fast,' a…
- Roche and Ionis report positive Phase 3 interim results for IgA nephropathy drug sefaxersenRoche and Ionis announced that their experimental RNA therapy sefaxersen met its primary endpoint in an interim analysis of a Phase 3 trial for IgA nephropathy. The trial showed statistically sign…